Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2021; 67(4): 76-85


E.O. Kindrativ1, V.M. Vasylyk2, V.M. Matskevych2, V.M. Kostyuk1, V.A. Semchenko1, V.O. Voronych1

    1Ivano-Frankivsk National Medical University; 2PNPE (Public Non-Profit Enterprise) «Regional Clinical Hospital of Ivano-Frankivsk Regional Council»;


There was performed a statistical analysis of 164 records of pathological examination of persons who died of coronavirus disease during April-November, 2020. It is determined that the share of males was 62.20%, and females – 37.80%; the average age of the deceased persons was 64.40 ± 13.79 years. The largest number of lethal cases (57.32%) falls on the age category of 60-79 years, and the smallest (6.71%) – on the age category of 20-39 years. It is important that men predominate in all age groups. The most common direct causes of death were: respiratory failure – 78.05%, multiorgan failure – 17.07%. At the same time, respiratory insufficiency was dominant in all age categories, while the share of multiorgan failure was the largest in the group of persons aged 20-39 years. As a result of the analysis of thromboembolic complications found in 10.37% of cases, there were 3.05% of cases of acute coronary syndrome and acute cerebrovascular disorder, 1.83% of cases – acute thrombosis of the arteries of the lower extremities, 1.22% of cases – acute thrombosis of the mesenteric vessels, and 0.61% – disseminated intravascular coagulation of blood and acute pulmonary thromboembolism. Morphological examination of the lung tissue of the deceased persons revealed signs of diffuse alveolar damage involving the microcirculatory bed vessels in the pathological process. According to the results of bacteriological examination of the lungs there were revealed some signs of bacterial infection in 51.83% of cases, and signs of fungal infection – in 15.85% of cases. The most common (23.78%) was the growth of Klebsiella pneumoniae. The most common comorbidities were: coronary heart disease – 62.20%, hypertension – 29.27%, non-insulin dependent diabetes mellitus – 11.59%, obesity – 10.37%, anemia – 6.71% and chronic obstructive pulmonary disease – 2.44%. In 10.98% of cases diabetes was the main underlying disease. The data obtained may indicate an adverse effect of these diseases on the course of coronavirus disease.

Keywords: coronavirus disease; COVID-19; mortality; retrospective analysis; pathophysiology; morphology


  1. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19, March 2020. Geneva, Switzerland: World Health Organization; 2020. detail/who-director-general-s-opening-remarks-at-themedia-briefingon-covid-19-11-march-2020.
  2. Khimion LV Coronavirus disease: new humans challenge and known approaches to treatment. Family Med. 2020;1-2:87-8. view/204388/204170 [Ukrainian]. CrossRef #statisticContainer OWID_WRL
  3. Elezkurtaj S, Greuel S, Ihlow J, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Reports, 2021;11: 42-63. CrossRef PubMed PubMedCentral
  4. Ahrenfeldt, LJ, Otavova, M, Christensen K. et al. Sex and age differences in COVID-19 mortality in Europe. Wien Klin Wochenschr, 2021;133, 393-8. CrossRef PubMed PubMedCentral
  5. Austad SN, Fischer KE. Sex differences in lifespan. Cell Metab. 2016;23(6):1022-33. CrossRef PubMed PubMedCentral
  6. Grandi G, Facchinetti F, Bitzer J. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role? Eur J Contracept Reprod Health Care. 2020;25(3):233-4. CrossRef PubMed
  7. Mansueto G. COVID-19: Brief check through the pathologist's eye (autopsy archive), Pathol Res Pract. 2020;216:153195. CrossRef PubMed PubMedCentral
  8. Mansueto G, Niola M, Napoli C. Can COVID 2019 disease induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases? Pathol Res Pract. 2020;216:153086 10.1016/j.prp.2020.153086 CrossRef PubMed PubMedCentral
  9. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782-93. CrossRef PubMed
  10. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7. CrossRef PubMed PubMedCentral
  11. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-6. CrossRef PubMed
  12. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. CrossRef PubMed PubMedCentral
  13. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L COVID-19 pneumonia: different respiratory treatment for different phenotypes? Intensive Care Med, 2020;46:1099-102. CrossRef PubMed PubMedCentral
  14. Copin MC, Parmentier E, Duburcq T, et al. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med 2020;46:1124-6. CrossRef PubMed PubMedCentral
  15. Cox MJ, Loman N, Bogaert D, O'Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020; 1:e11. CrossRef
  16. David M, Morens, Jeffery K. Taubenberger, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness,J Infect Dis. 2008;198(7): 962-70. CrossRef PubMed PubMedCentral
  17. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. CrossRef
  18. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13. CrossRef
  19. Ucpinar BA, Sahin C, Yanc U. Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: case report. J Infect. Publ Health. 2020;13:887-9. CrossRef PubMed PubMedCentral
  20. Roufosse C, Curtis E, Moran L, et al. Electron microscopic investigations in COVID-19: not all crowns are coronas. Kidney Int. 2020;98(2):505-6. CrossRef PubMed PubMedCentral
  21. Mytsyk Y. 2019-nCoV pandemic: Impact on reproductive health. ProcShevchenko Sci Soc Med Sci. 2020;59(1): 81-4. CrossRef
  22. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-8. CrossRef PubMed PubMedCentral
  23. Cao W, Zhang C, Wang H, Wu Q, Yuan Y, Chen J, Geng S, Zhang X. Ischemic stroke: an underestimated complication of COVID-19. Aging Dis. 2021;12(3):691-704. CrossRef PubMed PubMedCentral
  24. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995-8. CrossRef PubMed PubMedCentral
  25. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020;71(15):889-90. CrossRef PubMed PubMedCentral
  26. Beach TG, Sue LI, Intorcia AJ, et al. Acute brain ischemia, infarction and hemorrhage in subjects dying with or without autopsy-proven acute pneumonia. medRxiv; 2021. CrossRef
  27. Barth RF, Buja LM, Parwani AV. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2. Diagn Pathol. 2020;15:85. CrossRef PubMed PubMedCentral
  28. Buja LM, Stone JR. A novel coronavirus meets the cardiovascular system: Society for cardiovascular pathology symposium. J Soc Cardiovascul Pathol. 2021;53:107336. Advance online publication. CrossRef PubMed PubMedCentral
  29. Chen C, Chen C, Yan JT, et al. Analysis of myocardial injury in patients with COVID19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;6:48.
  30. kpops/xls/kpops1220_ue.xls
  31. Tkachenko LO, Yepanchintseva OA, Todurov BM Potential impact of coronaviruses upon cardiovascular system under COVID-19 pandemic. Cardiac Surgery Interventional Cardiol. 2020;2:5-17. [Ukrainian]. CrossRef
  32. Piniazhko OB, Dumenko TM, Kovtun LI, Serediuk VV, Topachevsky OA. Estimation of quality-adjusted loss of life years (QALY) associated with COVID-19 mortality in Ukraine. Ukr Med J. 2020;3(2):137. [Ukrainian].

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.